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IL-17-producing T lymphocytes have been re-
cently shown to comprise a distinct lineage of
proinflammatory T helper cells, termed Th17
cells, that are major contributors to autoim-
mune disease. We show here that the orphan
nuclear receptor RORgt is the key transcription
factor that orchestrates the differentiation of
this effector cell lineage. RORgt induces tran-
scription of the genes encoding IL-17 and the
related cytokine IL-17F in naı¨ve CD4+ T helper
cells and is required for their expression in re-
sponse to IL-6 and TGF-b, the cytokines known
to induce IL-17. Th17 cells are constitutively
present throughout the intestinal lamina prop-
ria, express RORgt, and are absent in mice
deficient for RORgt or IL-6. Mice with RORgt-
deficient T cells have attenuated autoimmune
disease and lack tissue-infiltrating Th17 cells.
Together, these studies suggest that RORgt is
a key regulator of immune homeostasis and
highlight its potential as a therapeutic target in
inflammatory diseases.
INTRODUCTION
Effective adaptive immune responses to pathogenic and
commensal microorganisms require that lymphocytes be
endowed with effector properties appropriate for each
challenge. In response to microbe-induced cues from
the innate immune system, CD4+ helper T lymphocytes
thus differentiate in peripheral tissues to adopt a variety
of fates (Seder and Paul, 1994). Much focus has been
placed on two T helper cell subsets, the Th1 cells, which
produce interferon-g (IFNg), and the Th2 cells, which pro-
duce IL-4, IL-5, and IL-13 (Abbas et al., 1996; GlimcherCell 12and Murphy, 2000). Th1 cells control infections with intra-
cellular pathogens, including viruses and bacteria, but
they have also been implicated as the effectors in a variety
of autoimmune diseases (Christen and von Herrath, 2004;
Gately et al., 1998; Trembleau et al., 1995). Th1 differenti-
ation requires the cytokine IL-12 and the transcription fac-
tors, STAT4, STAT1, and T-bet (Szabo et al., 2000). Th2
cells control infections with helminths and other extracel-
lular microbes and are, in part, the effectors that mediate
the immunopathology of allergic responses and asthma.
Th2 cell differentiation requires the cytokine IL-4 and the
transcription factors STAT6 and GATA3 (Zheng and
Flavell, 1997).
It has recently been recognized that in many of the
mouse autoimmune diseasemodels that have been attrib-
uted to Th1 cells, disease severity is actually increased in
the absence of these cells. For example, experimental au-
toimmune encephalomyelitis (EAE) and collagen-induced
arthritis (CIA) are exacerbated in the absence of IFNg,
IFNg-R, STAT1, or IL-12 p35 (Iwakura and Ishigame,
2006; McKenzie et al., 2006). However, mice lacking the
IL-12 p40 subunit, which is shared with IL-23, are resistant
to these autoimmune diseases (Cua et al., 2003; Murphy
et al., 2003). This paradox has now been resolved by the
characterization of a third subset of T helper cells that se-
crete IL-17 (also known as IL-17A) and IL-17F and expand
in response to IL-23 independently of T-bet or STAT1 (Ag-
garwal et al., 2003; Harrington et al., 2005; Iwakura and
Ishigame, 2006; McKenzie et al., 2006; Park et al., 2005).
Mice lacking IL-17 are resistant to CIA and EAE (Nakae
et al., 2003), transfer of cells that produce IL-17 results
in severe disease (Langrish et al., 2005), and treatment
of mice with a neutralizing anti-IL-17 mAb suppresses
CNS autoimmune inflammation (Langrish et al., 2005).
The differentiation of the IL-17- and IL-17F-producing
cells, now termed Th17 cells, was initially shown to be de-
pendent on the presence, during antigen stimulation, of
IL-23 produced by the antigen-presenting cells (Aggarwal
et al., 2003; Harrington et al., 2005; Langrish et al., 2005;6, 1121–1133, September 22, 2006 ª2006 Elsevier Inc. 1121
Park et al., 2005). Consistent with this observation, mice
deficient for the p19 subunit of IL-23 failed to produce
Th17 cells and were resistant to EAE, CIA, and inflamma-
tory bowel disease (IBD) (Cua et al., 2003; Langrish et al.,
2005; Yen et al., 2006).
Although IL-23 has a key role in Th17-mediated inflam-
mation in vivo, recent studies have demonstrated that
in vitro polarization of naı¨ve CD4+ T cells toward the Th17
lineage requires a combination of T cell antigen receptor
(TCR) stimulation and the cytokines TGF-b and IL-6 but
is independent of IL-23 (Bettelli et al., 2006; Veldhoen
et al., 2006). Rather, IL-23 may be required for maintaining
the Th17 phenotype or for promoting survival and/or pro-
liferation of these cells. Overexpression of TGF-b in vivo
also results in a marked increase of encephalitogenic
Th17 cells following immunization with MOG antigen and
complete Freund’s adjuvant (Bettelli et al., 2006). TGF-b
had been thought of primarily as an anti-inflammatory
cytokine, in part because it induces in vitro differentiation
of Foxp3-expressing regulatory T cells (Tregs) (Chen et al.,
2003; Fantini et al., 2004). Thus TGF-b may induce either
anti-inflammatory Tregs or proinflammatory Th17 cells,
depending on the presence of IL-6.
The intestinal tract harbors a large fraction of the body’s
lymphatic tissue. Most T lymphocytes within the intestinal
epithelium and lamina propria have an effector phenotype
and are thought to be involved in maintaining a homeo-
static balance between the luminal commensal microflora
and the tissues of the intestine (Mowat, 2003). Innate im-
mune signaling pathways involving Myd88 are required
for repair of intestinal epithelium, suggesting that
increased exposure of cells within the lamina propria to
commensal microorganisms results in signals that acti-
vate regenerative processes (Rakoff-Nahoum et al.,
2004). The cells involved in such processes and the medi-
ators of homeostatic signals have yet to be characterized.
Organized lymphoid structures in the lamina propria, in-
cluding cryptopatches and isolated lymphoid follicles
(ILFs), may receive signals from dendritic cells that sur-
round them and can sample luminal content (Hamada
et al., 2002; Kanamori et al., 1996; Newberry and Lorenz,
2005; Niess et al., 2005; Rescigno et al., 2001). Differenti-
ation of these lymphoid tissues, as well as lymph nodes
and Peyer’s patches, is dependent on the orphan nuclear
receptor RORgt. This transcription factor is required for
the development of lymphoid tissue inducer (LTi) cells
and LTi-like cells that guide development of the lymphoid
tissues within the fetus and in the adult intestine, respec-
tively (Eberl and Littman, 2004; Sun et al., 2000).
RORgt is expressed in double-positive (CD4+CD8+) thy-
mocytes, extending their survival during clonal selection,
and in the LTi and LTi-like cells (Eberl et al., 2004). Here
we show that RORgt is also expressed in populations of
intestinal lamina propria T lymphocytes, most of which
constitutively produce IL-17, and that these cells are ab-
sent in RORgt-deficient mice. In addition, both cytokine-
directed in vitro differentiation of Th17 cells and in vivo
Th17-mediated inflammatory disease require induction1122 Cell 126, 1121–1133, September 22, 2006 ª2006 Elsevierof RORgt. Our results demonstrate that RORgt is the tran-
scription factor that directs the differentiation of inflamma-
tory Th17 cells.
RESULTS
RORgt Is Expressed in a Subset of Lamina Propria
T Cells and Is Required for Expression of IL-17
To examine the role of RORgt in T cell development and
lymphoid organogenesis we previously generated mice
with a GFP reporter cDNA knocked-in at the site for initia-
tion of RORgt translation (Eberl et al., 2004). Using these
animals we found that RORgt is expressed at the dou-
ble-positive stage of T cell development but is absent in
more mature thymocytes and in mature T cells in spleen
and peripheral LNs (Eberl et al., 2004). In the periphery,
we had found that GFP (or RORgt) expression was limited
to a population of RORgt-dependent lymphoid-tissue in-
ducer cells (LTi) in the fetus and a population with a similar
phenotype in adult intestinal cryptopatches and lymphoid
follicles (Eberl and Littman, 2004; Sun et al., 2000). Upon
closer examination of lamina propria cells from Rorgtgfp/+
mice, we observed subpopulations of TCRab+ and TCRgd+
cells that expressed a lower level of GFP than the LTi-like
TCR-negative cryptopatch cells. Approximately 10% of
TCRab+ T cells, most of which were CD4+, and 50% of
TCRgd+ T cells expressed GFP (Figure 1A). In Rorgtgfp/gfp
mice, which lack expression of RORgt, the LTi-like cells,
which are LinGFP+, were completely absent. In contrast,
the GFP+TCRab+ T cells were still present, although re-
duced to 50%–75%, and the GFP+TCRgd+ T cells were
no longer observed (Figure 1B). RORgt (GFP) expression
was not detected in the intestinal epithelial cell (IEL) com-
partment ofRorgtgfp/+ or Rorgtgfp/gfpmice (Figure S1 avail-
able with the Supplemental Data online).
In experiments aimed at investigating the mechanisms
that regulate Th17 cell differentiation, we performed Affy-
metrix gene chip analysis of CD4+ T cells cultured under
conditions favoring Th17 (grown in IL-23) versus Th1
(grown in IL-12) differentiation. In Th17 culture conditions,
RORgt mRNA levels were found to be elevated (B.S.M.
and D.J.C., unpublished data). The finding of RORgt+ T
cells in the intestinal lamina propria therefore raised the
possibility that these cells were of the Th17 lineage.
When lamina propria lymphocytes (LPL) from Rorgtgfp/+
mice were isolated and stimulated for 5 hr with anti-
CD3/CD28, we found that a large proportion of the GFP+
cells, but not the GFP cells, indeed expressed IL-17
(Figure 2A).
In Rorgtgfp/+ and in wild-type mice, approximately 10%
of CD4+TCRab+ intestinal T cells expressed IL-17
(Figure 2B and data not shown). However, in RORgt null
(Rorgtgfp/gfp) mice, IL-17+ cells in the lamina propria were
reduced by at least 10-fold to less than 1% of the CD4+
T cells, suggesting that RORgt may be necessary for the
generation of Th17 cells in vivo (Figure 2B). Both IL-17
and RORgt (GFP) were also expressed in CD4 T cells inInc.
Figure 1. RORgt Is Expressed in a Subpopulation of Lamina Propria T Cells
(A) Lamina propria lymphocytes (LPL) were isolated from the small intestine and colon of heterozygous RORgt-reporter mice (Rorgtgfp/+) and stained
for TCRb and TCRgd. Representative data from multiple experiments are shown.
(B) Expression of RORgt (GFP) in the small intestinal lamina propria of heterozygous (Rorgtgfp/+) and homozygous (Rorgtgfp/gfp) RORgt-reporter mice.the lamina propria and were reduced in RORgt-deficient
mice (Figure 2B and Figure S2).
In mice kept under specific pathogen-free conditions,
IL-17+ cells were present in the lamina propria of the small
intestine (proximal and distal), cecum, colon, and rectum.
However, the small intestinal lamina propria contained the
largest proportion of IL-17+ T cells and the cecum con-
tained the smallest (Figure S3). Very few cells in the IEL
compartment (0.1%–0.2% of TCRab and TCRgd cells)
expressed IL-17 (data not shown). We did not observe
RORgt/GFP+ or IL-17+ T cells outside of the intestine in
other secondary lymphoid organs. These observations
suggest that signals from the intestinal microflora may
regulate the differentiation of the intestinal Th17 cells in
the lamina propria. In an effort to investigate this possibil-
ity, we assessed the presence of IL-17+ cells in the lamina
propria of MyD88-deficient mice. We discovered only
a mild decrease in the percentage of these cells in the
mutant animals, indicating that if intestinal Th17 cells dif-
ferentiate in response to signals from the lumen, then
other signaling pathways are likely involved (Figure S4).
RORgt Is Required for the In Vitro Induction of IL-17
in T Helper Cells
It was recently reported that purified naı¨ve CD4+ T cells are
induced todifferentiate in vitro into Th17cells upon antigen
receptor ligation in the presence of IL-6 and TGF-b (Veld-
hoen et al., 2006). To test if RORgt is required for this differ-
entiation program,wepurifiedCD4+CD25CD62L+CD44
naı¨ve splenic T cells from wild-type and RORgt-deficient
mice and stimulated them in vitro with plate bound anti-
CD3 and soluble anti-CD28 for 3 days under various polar-
izing conditions. We confirmed that a combination of IL-6
and TGF-b in the presence of neutralizing antibodiesCell 1against IFNg and IL-4 resulted in robust induction of
IL-17 in wild-type cells, and that either cytokine alone or
IL-23 had no effect (Figure 3A and data not shown). In con-
trast, CD4+ T cells from Rorg/ mice (which lack both
RORg and RORgt) displayed a marked reduction in
IL-17+ cells after in vitro polarization. There was typically
at least a 50-fold decrease in the number of IL-17+ cells,
and the level of IL-17 staining in these cells was signifi-
cantly reduced (Figure 3A). Consistent with this observa-
tion, incubation of anti-CD3/CD28-stimulated T cells with
IL-6 plus TGF-b resulted in induction of RORgt mRNA, as
well as transcripts for IL-17 and IL-17F (Figure 3B). The
mRNA for RORgt peaked at 16 hr, whereas those for
IL-17 and IL-17F peaked later, at 48 hr, consistent with
RORgt regulation of IL-17 transcription. IL-6 and TGFb
on their own induced low levels of RORgt expression but
were unable to induce IL-17 mRNA or IL-17-producing T
cells (Figure 3C and data not shown).
The defect in RORgt-deficient mice was confined to
IL-17-producing T cells, as differentiation of IFNg-produc-
ing Th1 cells upon incubation with IL-12 was normal or
even enhanced with cells from the mutant mice as com-
pared to those from wild-type animals (Figure S5).
Forced Expression of RORgt Induces IL-17 in Naı¨ve
CD4+ T Cells
As RORgt appeared to be essential for Th17 cell differenti-
ation in response to cytokines, we wished to determine
whether its expression is sufficient to induce the Th17 lin-
eage program in naı¨ve T cells.Weused retroviral transduc-
tion to deliver RORgt to magnetic bead (MACS)-purified
CD4+ T cells or FACS-sorted CD4+CD25CD62L+CD44
T cells stimulated with anti-CD3/CD28. In the absence of
exogenous polarizing cytokines, overexpression of RORgt26, 1121–1133, September 22, 2006 ª2006 Elsevier Inc. 1123
Figure 2. RORgt Is Required for the Generation of Lamina Propria IL-17+ T Cells
(A) RORgt+ (GFP+) T cells from Rorgtgfp/+ mice express IL-17. LPLs were stimulated in vitro with plate bound anti-CD3/anti-CD28 for 5 hr and in the
presence of Brefeldin A for the final 2 hr, after which they were fixed and stained for intracellular IL-17 and GFP.
(B) Comparison of lamina propria IL-17+ and IFNg+ T cells inRorgtgfp/+ andRorgtgfp/gfpmice. Freshly isolated LPLs from heterozygous (Rorgtgfp/+) and
homozygous null (Rorgtgfp/gfp) mice were stimulated in vitro with PMA/Ionomycin for 5 hr or incubated with Brefeldin A only (no PMA/Iono) and stained
for CD4, TCRb, and intracellular cytokines. The gating used is shown in Figure S2. Representative data from multiple experiments are shown.resulted in the induction of IL-17 in a large fraction of the
transduced (GFP+) T cells from C57BL/6 or Balb/c mice
(Figure 4A). In contrast, no IL-17 was observed in cells
transduced with T-bet-IRES-GFP and IRES-GFP control
vectors. Analysis by quantitative RT-PCR indicated that
the forced expression of RORgt resulted in induced tran-
scription of both IL-17 and IL-17F (Figure 4B).
Transduction of the T-bet-encoding retrovirus resulted,
as expected, in the induction of IFNg, but not IL-17. Con-
versely, there was no IFNg induction upon overexpression
of RORgt. Instead, the number of IFNg-producing cells
was reduced in cells expressing RORgt (Figure 4A).
Even when the cells were cultured under Th1 polarizing-
conditions, RORgt expression still induced IL-17 expres-
sion (data not shown).
To eliminate any possibility that cytokines produced by
contaminating antigen-presenting cells contribute to the
induction of IL-17 by RORgt, we repeated the experiments
using highly purified naı¨ve CD4+ T cells. Transduction of
RORgt resulted in IL-17 expression in more than half of
the cells in the absence of exogenous cytokines (Fig-1124 Cell 126, 1121–1133, September 22, 2006 ª2006 Elsevierure 4C). Together, these results indicate that RORgt is
sufficient to induce expression of IL-17 and IL-17F in
antigen-stimulated naı¨ve CD4+ T cells and are consistent
with a role for RORgt downstream of its induction by
IL-6 and TGF-b.
IL-6 Is Required for RORgt Expression
in the Lamina Propria
IL-6-deficient mice have been shown to have normal num-
bers of T cells but are defective in the induction of auto-
immune diseases and display increased susceptibility to
a variety of pathogens (Eugster et al., 1998; Kopf et al.,
1994). To determine if IL-6 is required in vivo for the differ-
entiation of Th17 cells in the lamina propria, we character-
ized intestinal T cells from IL-6 mutant animals. Although
lamina propria T cells were present in normal numbers in
IL-6-deficient mice, IL-17+ cells were reduced by about
10-fold, similar to what was observed with RORgt-
deficient mice (Figure 5A).
Consistent with the flow cytometry data, quantitative
RT-PCR performed with RNA from sorted lamina propriaInc.
Figure 3. In Vitro Differentiation of Th17 Cells Requires RORgt
(A) Cytokine production by naive CD4+CD25CD62L+CD44 T cells fromwt andRorg/mice after stimulation with anti-CD3/CD28 for 3 days with or
without TGF-b and IL-6.
(B) Time course of RORgt, IL-17, and IL-17F mRNA expression following stimulation as in (A).
(C) RORgt, IL-17, and IL-17F mRNA expression following stimulation as in (A) at the 48 hr time point. Relative expression levels were measured by
quantitative real-time RT-PCR and were normalized to actin expression level using the standard curve method.
In (B) and (C), error bars represent standard deviation obtained using the standard curve method.TCRb+CD4+ cells demonstrated a reduction in IL-17 ex-
pression in the absence of IL-6. Moreover, in contrast to
lamina propria CD4+ T cells from wild-type (wt) mice,
those from IL-6-deficient mice did not express RORgt,
IL-17F, and the IL-23-specific chain of the IL-23R
(Figure 5B). These data suggest that IL-6 upregulates
RORgt and IL-23R in vivo in the lamina propria, thus pro-
moting the generation of Th17 cells in the intestine.
RORgt Is Required for Th17-Mediated Autoimmune
Inflammatory Disease
The experiments described above demonstrate that
RORgt is a transcription factor required for differentiation
of IL-17-producing Th17 cells in vitro and in the intestinal
lamina propria. Since Th17 cells have been shown re-
cently to be the major pathogenic population in several
models of autoimmune inflammation, including EAECell 1(Langrish et al., 2005; Park et al., 2005), we investigated
the role of RORgt in this model. EAE was induced in
wild-type and RORg-deficient mice by injecting MOG
35-55 peptide in complete Freund’s adjuvant and pertus-
sis toxin (PTX) at day 0 and PTX at day 2. Wild-type
C57BL/6 mice developed disease on days 10–11 and by
day 14 reached peak disease manifestation, with 80%
reaching a score of 4. RORg-deficient mice on the
C57BL/6 background did not show signs of disease until
day 22, at which point some mice developed mild disease
(maximum score of 2) that quickly subsided (Figure 6A).
Thus, in the absence of endogenous RORgt, mice are
less susceptible to EAE.
Although RORg-deficient mice contain largely normal
splenic architecture, they lack all peripheral lymph nodes.
It is therefore possible that the lack of lymph nodes alone
may have contributed to the delayed and reduced26, 1121–1133, September 22, 2006 ª2006 Elsevier Inc. 1125
Figure 4. Induction of IL-17 in CD4+ T Cells by Ectopic Expression of RORgt
(A) IL-17 and IFNg production in MACS-sorted CD4+ T cells isolated from wild-type C57BL/6 and Balb/c mice and transduced with retroviral vectors
encoding IRES-GFP (MIG), T-bet-IRES-GFP (T-bet), and RORgt -IRES-GFP (RORgt). Cells were analyzed after 5 days in culture.
(B) Relative expression levels of IL-17 and IL-17F mRNAs in retrovirally transduced MACS-sorted CD4+ T cells. Expression levels were monitored by
quantitative real-time RT-PCR, and data were normalized to GAPDH expression level using the standard curve method.
(C) IL-17 production in sorted naı¨ve CD4+ T cells (CD4+CD25CD62L+CD44) transduced with retroviral constructs encoding IRES-GFP (MIG) and
RORgt-IRES-GFP (RORgt).
In (B), error bars represent standard deviation obtained using the standard curve method.autoimmunity observed in Rorg/ animals. To address
this caveat, we employed models in which EAE was
induced after reconstitution of RAG2-deficient mice
(Rag2/), which contain all secondary lymphoid organs,
including lymph nodes, with either CD4+ splenocytes or
bone marrow from wild-type or Rorg/ mice. Transfer
of 1 3 107 CD4+ splenocytes from wild-type mice, fol-
lowed by induction of EAE 24 hr later, led to development
of disease in all animals by day 15 post-induction. In con-
trast, transfer of CD4+ splenocytes from Rorg/ mice
resulted in only mild disease or, more commonly, in no
disease (Figure 6B).1126 Cell 126, 1121–1133, September 22, 2006 ª2006 Elsevier InIn the bone marrow transfer model, we confirmed that
the reconstitution efficiency was similar after 11 weeks
in mice that received wild-type or RORg-deficient cells
(Figure S6 and data not shown), and EAE was then in-
duced. RAG-deficient mice reconstituted with wild-type
bone marrow cells developed disease as early as day 10
after immunization (Figure 6C). By day 14, 90% of the
mice had severe disease (score of 4) and most animals
were moribund and had to be sacrificed by day 20. In con-
trast, less than half of the RAG-deficient animals reconsti-
tuted with Rorg/ bone marrow cells developed some
disease, and this was relatively mild (Figure 6C). Together,c.
Figure 5. IL-6 Controls the Differentiation of RORgt+ Th17 Cells in the Lamina Propria
(A) Comparison of IL-17+CD4+ T cells in the lamina propria of wt (B6) and IL-6-deficient mice. LPLs were isolated from two 17-week-old mice of
each genotype and stimulated for 4 hr with PMA/Ionomycin in the presence of Brefeldin A.
(B) Levels of RORgt, IL-23R, IL-17, and IL-17F mRNA expression in sorted TCRb+CD4+ lamina propria T cells from wt and IL-6-deficient mice.
In (B), error bars represent standard deviation obtained using the standard curve method.these results show that RORgt is required for fulminant
EAE.
Despite the markedly reduced disease manifestations
in mice that received bone marrow cells from Rorg/ an-
imals, infiltrating T cells were present in the spinal cords at
levels similar to those in mice reconstituted with wild-type
cells (Figure S6). The total number ofmononuclear infiltrat-
ing cells was slightly lower in the RORg-deficient cell
transfers but did not reach statistical significance (3.4 ±
1.3 3 106 cells for wt, versus 2.0 ± 1.1 3 106 cells for
RORg-deficient mice on day 21). Mice that received
wild-type bone marrow before induction of EAE contained
both IFNg- and IL-17-producing T cells in the spinal cord
infiltrate (Figures 6D and 6E). Remarkably, more than half
of the IL-17-producing cells also expressed IFNg. In con-
trast, although IFNg-producing T cells were present in the
RORg-deficient T cell infiltrate, few of the infiltrating T cells
produced IL-17 (Figures 6D and 6E), irrespective of the
presence or absence of disease (Figure 6D). In addition,
MOG-specific IL-17+ cells could not be found in draining
lymph nodes from mice reconstituted with bone marrow
from mutant mice after 4 days of culture with MOG pep-
tide, although similar numbers of total MOG-specific T
cells were found in these cultures and those from control
mice, suggesting a similar frequency of MOG-specific T
cells in both groups (Figure S7). Similar results were ob-
tained in the analysis of mice in which EAE was induced
after transfer of CD4+ splenocytes. Although infiltrating
CD4+IFNg+ T cells were present in both groups, only
mice that received wild-type CD4+ T cells contained
IL-17+ cells in the spinal cord and developed disease
(Figure S8).
During EAE, lymphoid and myeloid cells in the inflam-
matory infiltrate elicit increased expression of a numberCell 126of proinflammatory cytokines and chemokines locally in
the CNS. To further assess the etiology of the residual dis-
ease in the RORg-deficient chimeras, we investigated the
local CNS inflammatory responses by real-time PCR. In-
duction of EAE in wild-type bone marrow chimeras led
to increased expression of the proinflammatory cytokine
genes previously reported, including IL-17, IL-17F, and
IL-6, as well as the chemokines CCL6, CCL9, CCL11,
CCL20, and CCL24 and the receptor CCR1 (Figure S9).
Consistent with the reduced number of Th17 cells,
RORg-deficient mice displayed significantly decreased
levels of the Th17 cytokines and chemokines in the spinal
cord during disease. However, IFNg and IFNg-regulated
chemokines (including MIG) were unchanged in the
RORg-deficient chimeras (FigureS9), consistentwith apri-
mary role of pathogenic Th17, rather than Th1, cells in the
disease process.
DISCUSSION
In this study, we have shown that the orphan nuclear re-
ceptor RORgt is the transcription factor that directs the
differentiation of IL-17-producing inflammatory T cells.
Recent studies have demonstrated that IL-17 is ex-
pressed at elevated levels in a variety of allergic and auto-
immune diseases in humans (Barczyk et al., 2003; Fujino
et al., 2003; Infante-Duarte et al., 2000; Lock et al.,
2002; Witowski et al., 2004), and that Th17 cells represent
a distinct lineage of T helper cells whose function is re-
quired in numerous animalmodels of autoimmune disease
(Dong, 2006; McKenzie et al., 2006). Within tissues, Th17
effector cells stimulate production of a variety of in-
flammatory chemokines, cytokines, metalloproteases,
and other proinflammatory mediators and promote, 1121–1133, September 22, 2006 ª2006 Elsevier Inc. 1127
Figure 6. Reduced Severity of EAE and Absence of Infiltrating Th17 Cells in Mice with RORgt-Deficient T Cells
(A) EAE disease course in wild-type and Rorg/ mice (data are from six C57BL/6 and three syngeneic Rorg/ mice).
(B) EAE disease course in RAG2-deficient mice reconstituted with MACS-purified CD4+ splenocytes from wild-type (wt) and Rorg/mice. Data are
representative of two independent experiments—n = 5 (wt), n = 3 (Rorg/).
(C) EAE disease course in RAG2-deficient mice reconstituted with total bone marrow cells from wild-type or Rorg/ animals (five animals in each
group). All recipient animals were irradiated with a sublethal dose (400 rads/animal) before reconstitution, and EAE was induced 11 weeks later.
To assess similar reconstitution efficiency, blood before disease induction as well as spleen populations on day 21 after induction were compared
between the two groups (Figure S6 and data not shown). Data are representative of three independent experiments.
(D and E) Cytokine production by lymphocytes isolated on day 21 after disease induction from the spinal cords of RAG-deficient mice reconstituted
with wt and Rorg/ bone marrow (experiment in Figure 6C). The cells were stimulated for 4 hr with PMA/Ionomycin and stained for surface markers
and intracellular cytokines. Representative FACS plots (gated on TCRb+CD4+ cells) from mice from each group are shown in (D). Clinical scores are
shown in parentheses. In theRorg/ group, 3 out of 5mice did not develop any clinical signs of disease (score 0), but all had considerable spinal cord
infiltrate. One is shown in (D). Similar results were achieved in three independent experiments. Tabulated results from all mice are presented in (E) as
percentage of TCRb+CD4+ cells in the spinal cord infiltrate. Total: all IL-17+ cells; IFNg+: IL-17+IFNg+ cells; IFNg: IL-17+IFNg cells; CD4+IFNg+:
IL-17IFNg+ cells. **p = 0.002, *p = 0.006, unpaired t test. Error bars represent standard deviation.recruitment of granulocytes (Kolls and Linden, 2004;
Stamp et al., 2004). We found that RORgt is required for
the constitutive expression of IL-17 in intestinal lamina
propria T cells and for the in vitro differentiation of Th17
cells from naı¨ve CD4+ T cells. Following ligation of the
antigen receptor, the cytokines IL-6 and TGF-b together
induce the transcription of RORgt, which, in turn, partici-
pates in andmay be sufficient for the induction of IL-17 ex-
pression. We have additionally shown a central role for
RORgt in the in vivo differentiation of pathogenic Th17
cells within the central nervous system in a model for in-1128 Cell 126, 1121–1133, September 22, 2006 ª2006 Elsevierflammatory autoimmune disease, EAE. Together, these
studies suggest that manipulation of RORgt activity may
be an attractive therapeutic strategy in a variety of dis-
eases with inflammatory etiology.
Regulation of the Th17 Differentiation Pathway
by RORgt
RORg and RORgt are both encoded within the Rorc locus
and differ only in their amino-terminal sequences due to
utilization of different promoters (Eberl and Littman,
2003). Both are members of the retinoic acid-relatedInc.
Figure 7. Model of Th17 Development in the Intestinal Lamina Propria
Th17 development in the gut requires RORgt expression in CD4+ T cells. RORgt expression results from the action of IL-6 and TGF-b (but not IL-23)
produced by activated dendritic cells (DCs) and other cells in the lamina propria. DCs can be activated by signals derived from the luminal flora or
infectious agents and TLR ligands that gain access to the lamina propria. It is currently unknown if IL-6, TGF-b, and IL-23 are produced by different
types of DCs or by the same DC. TGF-bmay also be derived from regulatory T cells (Tregs), which normally suppress Th1 and Th2 cell development.
IL-6 may also inhibit TGF-b-induced differentiation of Tregs, thus further promoting Th17 development. RORgt+ T cells upregulate IL-23R and thus
become responsive to IL-23. IL-23 reinforces the Th17 phenotype by possibly helping inmaintenance, expansion, or further differentiation of the cells.orphan nuclear hormone receptor family that also includes
RORa and RORb (Jetten, 2004). Whereas RORg is ex-
pressed broadly and as yet has no defined function,
RORgt is expressed exclusively in cells of the immune
system.
We previously showed that RORgt, but not RORg, is
expressed in fetal LTi cells, intestinal LTi-like cells, and
immature thymocytes (Eberl and Littman, 2004; Sun
et al., 2000). In this study, we found that subpopulations
of intestinal lamina propria T cells also express low levels
of RORgt, and many of these cells constitutively express
IL-17. In vitro, IL-6 and TGF-b induced transcription of
RORgt in purified CD4+ T cells prior to the onset of IL-17
and IL-17F expression. The expression of IL-17 in the in-
testinal T cells and in cytokine-stimulated CD4+ T cells
was dependent on the presence of RORgt. In addition,
lamina propria T cells from IL-6-deficient mice did not ex-
press RORgt or IL-17. Thus it is likely that, after T cells mi-
grate into the lamina propria, RORgt is induced locally by
the combination of IL-6 and TGF-b, which are abundant at
this site, resulting in differentiation of Th17 cells (Figure 7).
It was recently shown that TGF-b induces expression of
Foxp3 and promotes the differentiation of regulatory T
cells (Tregs) (Chen et al., 2003; Fantini et al., 2004). This
program was blocked by IL-6, which together withCell 1TGF-b induced IL-17 expression instead (Bettelli et al.,
2006). The relative balance of IL-6 and TGF-b may there-
fore control the local differentiation of Tregs and Th17 cells
at steady state in the intestine and in inflammatory condi-
tions in diverse tissues (Figure 7). Paradoxically, TGF-b
and IL-6 can individually induce expression of some
RORgt, but neither alone can induce IL-17. This may in
part be explained by the ability of Foxp3 to inhibit
RORgt-induced IL-17 expression (L.Z. and D.R.L., unpub-
lished data). It will be important to further dissect the tran-
scriptional networks that govern differential expression of
Foxp3 and RORgt in response to the cytokines. IFNg and
IL-4 have also been reported to interfere with Th17 dif-
ferentiation in vitro, raising the possibility that there is
reciprocal inhibition between the different T helper cell
differentiation pathways.
IL-23 is also involved in Th17 cell differentiation, but na-
ı¨ve T cells are IL-23 receptor negative and relatively refrac-
tory to IL-23 stimulation (Langrish et al., 2005; Oppmann
et al., 2000). Only following in vivo priming does in vitro
stimulation of T cells with antigen and antigen-presenting
cells plus IL-23 result in effective expansion of Th17 cells
(Langrish et al., 2005; Murphy et al., 2003; Veldhoen et al.,
2006). Our results suggest that IL-23R is upregulated on
RORgt+ Th17 cells in an IL-6-dependent manner (Figure 5;26, 1121–1133, September 22, 2006 ª2006 Elsevier Inc. 1129
L.Z. and B.S.M., unpublished data). IL-23 may therefore
function subsequent to IL-6/TGF-b-induced commitment
to the Th17 lineage to promote cell survival and expansion
and, potentially, continued expression of IL-17 and other
cytokines that characterize the Th17 phenotype (Figure 7).
It is not yet known if RORgt is required for sustained IL-17
expression in response to IL-23R-mediated signals in
effector/memory T cells.
Role of RORgt in Immune System Homeostasis
In healthy adult mice, RORgt has been detected only in im-
mature thymocytes and in cells residing in the intestinal
lamina propria. In the intestine, RORgt is required for the
differentiation of Th17 cells and of LTi-like cells that form
cryptopatches and appear to be critical for differentiation
of isolated lymphoid follicles (ILFs) (Eberl and Littman,
2004). It is intriguing that two types of RORgt-dependent
cells with very different mechanisms of action are both
positioned at amucosal surface that is in constant interac-
tion with an enormous amount of microbial flora. The
cryptopatch cells and the Th17 cells may be regulated
coordinately, perhaps by a ligand for RORgt, to maintain
homeostasis of themicroflora and integrity of the epithelial
barrier. Cryptopatches are located at the base of intestinal
crypts and are thus positioned to receive signals from the
intestinal lumen and transmit them to other cells in the
lamina propria and to crypt epithelial cells. Development
of mature ILFs requires signals from the gut flora (Lorenz
et al., 2003; Pabst et al., 2005; Taylor and Williams,
2005) that may induce recruitment of B lymphocytes to
cryptopatches (Ivanov et al., 2006). Signals from the gut
flora may also be responsible for the unique presence of
Th17 cells in the intestinal mucosa.
Th17 cells are likely to be required to control infections
at mucosal surfaces. IL-23-deficient mice are unable to
control orally administered Citrobacter rodentium, which
stimulates expansion of lamina propria Th17 cells (Man-
gan et al., 2006). IL-17 and IL-23 have also been shown
to be important in protecting mice from lung infection
with Klebsiella pneumoniae (Happel et al., 2005; Ye
et al., 2001). By inducing chemokine and G-CSF expres-
sion from surrounding cells, RORgt-dependent Th17 cells
promote expansion and recruitment of neutrophils that
can control these microorganisms if they breach the epi-
thelial barrier. In vitro studies using intestinal epithelial
cell cultures showed that IL-17 could enhance tight-junc-
tion formation that is crucial for the protective function of
the gut mucosa (Kinugasa et al., 2000). In an acute model
of colitis induced by dextran sulfate sodium, which strips
the intestinal mucosal barrier, neutralization of IL-17 exac-
erbated colonic inflammation (Ogawa et al., 2004). These
results suggest that RORgt-mediated induction of IL-17
expression can also have a protective or regenerative
function when epithelial damage occurs.
It is unknown if RORgt directly induces IL-17 transcrip-
tion in Th17 cells. ROR response elements (ROREs) con-
sist of the consensus core motif AGGTCA preceded by
a 5 bp A/T-rich sequence (Jetten et al., 2001). We per-1130 Cell 126, 1121–1133, September 22, 2006 ª2006 Elsevieformed a search for potential ROREs within the il17 locus
and identified an evolutionarily conserved RORgt binding
site within the 200 bp core promoter region, suggesting
that transcription of IL-17 may be directly regulated by
RORgt (data not shown). Whether RORgt activity is regu-
lated by a ligand is not yet known. Exposure to a ligand in
the intestine could potentially regulate the transcriptional
activity of RORgt and may thus govern formation of folli-
cles, differentiation of effector T cells, and even the
dynamic equilibrium of the epithelial barrier.
Central Role of RORgt in Inflammatory Diseases
During the past year, it has become increasingly clear that
T helper cells that secrete IL-17, rather than IFNg-produc-
ing Th1 cells, are the major inflammatory cells in a number
of disease models, and that function of these cells is
dependent on IL-23 (Chen et al., 2006; Cua et al., 2003;
Langowski et al., 2006; Mangan et al., 2006; Yen et al.,
2006). In EAE, Th17 cells are far more potent than IFNg-
producing Th1 cells, with as few as 13 105 IL-17-produc-
ing T cells sufficient to transfer disease to naı¨ve recipients
(Langrish et al., 2005). We found that RORgt is required for
pathogenic Th17 responses in EAE. In the CNS of animals
with RORgt-deficient T cells, the cytokines characteristic
of Th17 cells were significantly reduced, but Th1 cytokines
were normally expressed. The absence of Th17 cells led to
a decrease in proinflammatory chemokines, consistent
with the role of the IL-23-IL-17 pathway in recruiting
inflammatory cells to sites of inflammation (McKenzie
et al., 2006; Stark et al., 2005). RORgt-dependent mecha-
nisms that normally regulate host defense by promoting
neutrophil mobilization and tissue repair are therefore
also critical in initiating tissue-specific inflammatory
responses.
Consistent with a key role for RORgt-dependent Th17
cells in autoimmunity, we have found that mRNAs for
both RORgt and IL-17 are significantly increased in skin
from psoriasis patients (B.S.M. and D.J.C., unpublished
data). This and recent findings of elevated IL-17 levels in
human autoimmune diseases suggest that intervention
with RORgt activity and, hence, with the differentiation
of Th17 cells may be of significant therapeutic benefit.
Our results indicate that RORgt has a role in Th17 differen-
tiation that resembles the roles of T-bet and GATA-3 in the
differentiation of Th1 and Th2 cells, respectively. Unlike
these other transcription factors, RORgt is a nuclear re-
ceptor with a ligand binding pocket, and it is hence likely
to be an excellent target for pharmacologic intervention




Mice with a GFP reporter cDNA knocked-in at the site for initiation of
RORgt translation (Eberl et al., 2004), as well as Rorg/ mice on the
C57BL/6 background (Sun et al., 2000), have been described and
were kept in SPF conditions at the animal facility of the Skirball
Institute. Myd88/ mice were provided by Dr. Ruslan Medzhitovr Inc.
(Yale University). Il6/ mice on the C57BL/6 background were pur-
chased from the Jackson laboratory and were provided by Dr. Joel
Ernst (NYU). C57BL/6, Balb/c, and Rag2/ mice were purchased
from Taconic. All animal experiments were performed in accordance
with approved protocols from the NYU Institutional Animal Care and
Usage Committee.
EAE Induction and Disease Scoring
For induction of EAE, mice were immunized subcutaneously on day
0 with 150 mg/mouse MOG 35-55 peptide (Molecular Biology Core
Facilities, Dana-Farber Cancer Institute, Harvard University), emulsi-
fied in CFA (CFA supplemented with 400 mg/mlMycobacterium tuber-
culosis), and injected intravenously on days 0 and 2with 200 ng/mouse
of pertussis toxin (Calbiochem). The basic scoring system used was
0—no disease, 1—limp tail, 2—weak/partially paralyzed hind legs,
3—completely paralyzed hind legs, 4—complete hind and partial front
leg paralysis, 5—complete paralysis/death. Mice with disease levels 4
and 5 were considered moribund and were euthanized.
Bone Marrow Reconstitutions
Total bone marrow mononuclear cells were isolated from wild-type
and Rorg/ mice by flushing the long bones. Red blood cells were
lysed with ACK Lysing Buffer (BioWhittaker) and the remaining mono-
nuclear cells were resuspended in PBS for injection. 5–10 3 106 cells
per mouse were injected intravenously into 3- to 5-week-old Rag2/
mice that were sublethally irradiated using 400 rads/mouse 4 hr
before reconstitution. EAE was induced 11 weeks post bone marrow
reconstitution.
CD4+ T Cell Transfers
Single-cell suspensions were prepared from spleens of wild-type and
Rorg/ mice and CD4+ cells purified by using anti-CD4 magnetic
microbeads (Miltenyi Biotec) and MACS columns (purity was >95%,
usually 97%–98%). 107 CD4+ cells per mouse were injected intra-
venously into unirradiated Rag2/mice. EAE was induced 24 hr after
transfer.
Isolation of Lamina Propria Lymphocytes
and Intraepithelial Lymphocytes
Mice were killed and intestines removed and placed in ice-cold PBS.
After removal of residual mesenteric fat tissue, Peyer’s patches were
carefully excised, and the intestine was opened longitudinally. The
intestine was then thoroughly washed in ice-cold PBS and cut into
1.5 cm pieces. The pieces were incubated twice in 5 ml of 5 mM
EDTA in HBSS for 15–20min at 37Cwith slow rotation (100 rpm). After
each incubation, the epithelial cell layer, containing the intraepithelial
lymphocytes (IELs), was removed by intensive vortexing and passing
through a 100 mmcell strainer and new EDTA solution was added. After
the second EDTA incubation the pieces were washed in HBSS, cut in
1 mm2 pieces using razor blades, and placed in 5 ml digestion solution
containing 4% fetal calf serum, 0.5 mg/ml each of Collagenase D
(Roche) and DNase I (Sigma), and 50 U/ml Dispase (Fisher). Digestion
was performed by incubating the pieces at 37C for 20 min with slow
rotation. After the initial 20min, the solutionwas vortexed intensely and
passed through a 40 mm cell strainer. The pieces were collected and
placed into fresh digestion solution and the procedure was repeated
a total of three times. Supernatants from all three digestions (or from
the EDTA treatment for IEL isolation) from a single small intestine
were combined, washed once in cold FACS buffer, resuspended in
10 ml of the 40% fraction of a 40:80 Percoll gradient, and overlaid on
5 ml of the 80% fraction in a 15 ml Falcon tube. Percoll gradient sep-
aration was performed by centrifugation for 20 min at 2500 rpm at
room temperature. Lamina propria lymphocytes (LPLs) were collected
at the interphase of the Percoll gradient, washed once, and resus-
pended in FACS buffer or T cell medium. The cells were used immedi-
ately for experiments.CellIsolation of Mononuclear Cells from Spinal Cords
Before spinal cord (SC) dissection, mice were perfused with 25 ml
2 mM EDTA in PBS to remove blood from internal organs. The spinal
columns were dissected, cut open, and intact SCs separated carefully
from the vertebrae. The SCs were cut into several small pieces and
placed in 2 ml digestion solution containing 10 mg/ml Collagenase D
(Roche) in PBS. Digestion was performed for 45 min at 37Cwith short
vortexing every 15min. At the end of the digestion the solutionwas vor-
texed intensively and passed through a 40 mm cell strainer. The cells
were washed once in PBS, placed in 6 ml of 38% Percoll solution,
and pelleted for 20 min at 2000 rpm. Pellets were resuspended in
FACS buffer or T cell medium and used for subsequent experiments.
Isolation of Total and Naı¨ve CD4+ T Cells
CD4+ T cells were purified from spleens using anti-CD4 magnetic
microbeads (Miltenyi Biotec) and MACS columns (purity was >95%).
For naive CD4+ T cells, single-cell suspensions were first negatively
depleted by staining with anti-B220-PE, anti-CD8a-PE, anti-CD11b-
PE, anti-CD11c-PE, anti-CD49b-PE, all at 1:100 dilution, and anti-
Ter119-PE at 1:66 dilution, for 20 min on ice, followed by incubation
with anti-PE magnetic microbeads (Miltenyi Biotec) at 1:20 dilution
for 20 min on ice. The depleted fraction was stained with anti-CD25-
PE, anti-CD4-PECy7, anti-CD62L-FITC, and anti-CD44-APC. Cell
sorting was performed on a MoFlo cytometer (DAKO Cytomation) to
obtain a pure population of naı¨ve CD4+CD25CD44lowCD62L+ T cells
(>99% purity).
Surface and Intracellular Cytokine Staining
For intracellular cytokine staining, cells obtained from in vitro culture or
from dissection of lamina propria or spinal cords were incubated for
4–5 hr with 50 ng/ml PMA (Sigma), 750 ng/ml Ionomycin (Sigma),
and 10 mg/ml Brefeldin A (Invitrogen) in a tissue culture incubator at
37C. Surface staining was performed for 15–20 min with the corre-
sponding cocktail of fluorescently labeled antibodies. After surface
staining, the cells were resuspended in Fixation/Permeabilization
solution (BD Cytofix/Cytoperm kit—BD Pharmingen), and intracellular
cytokine staining was performed as per the manufacturer’s protocol.
Flow Cytometry and Antibodies
Flow cytometric analysis was performed on LSR II (BD Biosciences) or
FACSCalibur (BD Biosciences) instruments and analyzed using
FlowJo software (Tree Star Inc.). All antibodies were purchased from
BD Pharmingen or eBiosciences. In cases where intracellular cytokine
staining was performed, GFP fluorescence was detected with anti-
GFP-Alexa 488 (polyclonal rabbit IgG fraction—Molecular Probes).
Plasmids and Retrovirus Production
The RORgt cDNA was PCR amplified and cloned into pMIG (RORgt-
IRES-GFP). T-bet-IRES-GFP was a kind gift from Dr. Steve Reiner
(University of Pennsylvania). Phoenix cells were transfected with
9 mg of the indicated plasmids using Lipofectamin 2000 (Invitrogen).
Viral supernatant was collected and supplemented with 8 mg/ml poly-
brene (Sigma).
Cell Culture and Retroviral Transduction
The T cell culture medium used was RPMI Media 1640 (Invitrogen)
supplemented with 10% Fetal Calf Serum (Hyclone), 2 mM L-gluta-
mine, 100 U/ml penicillin, 100 mg/ml streptomycin, 5 mM 2-b-mercap-
toethanol. 1.5 3 106/well MACS-purified CD4+ T cells or sorted naive
CD4+ T cells were cultured in 24-well plates (or 0.73 106 cells per well
in 48-well plates) containing plate bound anti-CD3 (5 mg/ml) and solu-
ble anti-CD28 (1 mg/ml); cultures were supplemented with 40 U/ml
mouse IL-2 (Roche), 10 mg/ml anti-IL-4 (BD Pharmingen), 10 mg/ml
anti-IFN-g (BD Pharmingen) with or without 20 ng/ml IL-6 (eBio-
science), and 5 ng/ml TGF-b (Preprotech). For flow cytometry cells
were analyzed on days 3 and 5.126, 1121–1133, September 22, 2006 ª2006 Elsevier Inc. 1131
For viral transduction, sorted naı¨ve CD4+ T cells were plated as
above in the absence of TGF-b and IL-6 on day 0. On days 1 and 2,
fresh retrovirus supernatant was added and the cells were spun at
2500 rpm for 1.5 hr at 30C. After spin infection, the cells were cultured
in the T cell culturemedium and harvested on day 5 or 6 for intracellular
cytokine staining and real-time PCR (RT-PCR) analysis.
RT-PCR
cDNA was synthesized with RNA prepared by TRIZOL using RNase
H-reverse transcriptase (Invitrogen). cDNA was analyzed by real-
time quantitative PCR in triplicates by using iQ CYBR Green Supermix
(Bio-Rad) or QuantiTect Multiplex PCR mix (Qiagen) in the iCycler
Sequence Detection System (Bio-Rad). The starting quantity (SQ) of
the initial cDNA sample was calculated from primer-specific standard
curves by using the iCycler Data Analysis Software. The expression
level of each gene was normalized to actin expression level using stan-
dard curve method. The primer sets for real-time PCR can be found in
the Supplemental Data.
Supplemental Data
Supplemental data include Experimental Procedures, References, and
nine figures and can be found with this article online at http://www.cell.
com/cgi/content/full/126/6/1121/DC1/.
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